I just saw that Qu Biologics has posted data on their ulcerative colitis trial. It was a small studi, but the results seem very promising.
In the study, 8 of the 11 (73%) QBECO SSI treated participants achieved clinical response and 5 patients (45%) had endoscopic healing within the first 16 weeks of treatment with one patient in clinical and endoscopic remission by study week 8 [1]. Importantly, histological improvement occurred in 6 of 11 (55%) trial participants, including 6 of 8 (75%) responders.
have they released data like this on the trials they've done with Crohn's disease? Does anyone know when we can expect more data on the effectiveness in crohns? I hope it's not a bad sign that they've posted actual data for UC, but have only released vague results for the crohns trial